However, ongoing studies, including perianal fistulizing disease trials and the REASON study evaluating transmural healing, will address some of these knowledge gaps in the future. For patients, the ...

An expert discusses how underutilization of combination lipid-lowering therapies stems from overly complex guidelines, primary care providers managing multiple chronic diseases simultaneously, cost ...

Kenneth A. Beckman, M.D., doesn’t see insurers as standing in the way of patients getting treated with the “epi-on” approach ...

In an interview conducted by Ophthalmology Times on behalf of Managed Healthcare Executive, Beckman listed some of the ...

Beckman said it is important to treat keratoconus with corneal collagen crosslinking early to prevent vision loss, although ...

More than two decades after the September 11 attacks, new research suggests that responders who worked amid the World Trade Center (WTC) dust and debris face nearly a 3-fold higher incidence of lung ...

Bandyopadhyay and colleagues found that new T1D registrations were most likely to come from people under the age of 40, ...

Researchers of the National Eye Institute found that the supplement—now known as the AREDS formula, containing vitamins C and ...

The FDA has approved Genentech’s Gazyva (obinutuzumab) for the treatment of lupus nephritis in adults, according to a news release published today. Gazyva is the first and only anti-CD20 monoclonal ...

Cobenfy represents a breakthrough schizophrenia treatment with a novel mechanism, but limited long-term data requires ...